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Abstract: Introduction: The double pressure reserve (DPR) has recently been shown to have greater prognostic power 
than metabolic equivalents, heart rate indices, and systolic blood pressure in healthy subjects. It is unclear whether DPR 
offers any prognostic value in a heart failure population where variables derived from metabolic gas exchange data pro-
vide important prognostic information. 
Methods: Patients underwent a symptom-limited, treadmill-based exercise test with metabolic gas exchange measure-
ments using the modified Bruce protocol. DPR was calculated as the product of peak systolic blood pressure and peak 
heart rate subtracted from the product of resting systolic blood pressure and resting heart rate values.  
Results: 363 patients (mean ± SD; age 74±11 years; 81% males; left ventricular ejection fraction 34±6%; peak VO2 19.0 ± 
5.1 mL·kg
-1
·min
-1
; VE/VCO2 slope 37 ± 9; double pressure reserve 10,510 ± 6,046 mmHg·beat
-1
) were included in the 
study. Peak VO2 (hazard ratio (HR) = 0.87; P<0.0001, 95% confidence intervals (CI) = 0.75-0.99), VE/VCO2 slope 
(HR=1.03; P=0.04; 95% CI =1.00-1.06), and age (HR=1.02; P=0.09; 95% CI =0.98-1.05) were the strongest independent 
predictors of mortality. DPR was not a univariate predictor of mortality (P=0.7; HR=1.0; 95% CI = 0.99-1.0). 
Conclusion: DPR does not predict mortality in patients with CHF. Traditional prognostic markers derived from metabolic 
gas exchange including peak VO2 and the VE/VCO2 slope are more important.  
Keywords: Systolic blood pressure, heart rate, CPET, ventilation, mortality. 
INTRODUCTION 
 Cardiopulmonary exercise testing (CPET) with metabolic 
gas exchange is a standard test for predicting survival in pa-
tients with chronic heart failure (CHF). CHF patients have an 
impaired response to exercise as shown by a lower peak 
oxygen uptake [1] and anaerobic threshold than healthy sub-
jects [2]. Patients with CHF also have an increase in the 
slope relating ventilation (VE) to carbon dioxide production 
(VCO2), which is also related to survival [3, 4]. 
 Recently, Rafie and colleagues [5, 6] showed that the 
double product reserve (DPR) was a better predictor of mor-
tality than metabolic equivalents, maximal heart rate (HR), 
systolic blood pressure or HR recovery in 1,655 normal men 
referred for assessment of exercise capacity. To our knowl-
edge, no previous studies have compared the prognostic 
value of the DPR against traditional predictors of mortality 
derived from metabolic gas exchange in a heart failure popu-
lation. The aim of our study was to evaluate the relative 
prognostic significance of the DPR in patients with CHF.  
METHODS 
 The Hull and East Riding Ethics Committee approved the 
study,
 
and all patients provided informed consent prior to the 
study. We recruited consecutive patients referred to a com 
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munity heart failure clinic with symptoms of breathlessness 
(NYHA functional class II-III) who were found to have left 
ventricular systolic dysfunction on investigation. Clinical 
information obtained included past medical history and drug 
and smoking history. Clinical examination included assess-
ment of body mass index (BMI), heart rate, rhythm, and 
blood pressure. Patients were excluded
 
if they were unable to 
walk without assistance from another
 
person (not including 
mobility aids), or if they were unable
 
to exercise because of 
non-cardiac limitations such as osteoarthritis or respiratory 
disease defined as a predicted FEV1 <70%.  
 Heart failure (HF) was defined as the presence of current 
symptoms of HF, or a history of symptoms controlled by 
ongoing therapy, due to cardiac dysfunction and in the ab-
sence of any more likely cause [7]. Left ventricular function 
was determined from 2D echocardiography and was carried 
out by one of three trained operators. Left ventricular func-
tion was assessed by estimation on a scale of normal, mild, 
mild-to-moderate, moderate, moderate-to-severe, and severe 
impairment and was assessed by a second operator blind to 
the assessment of the first; where there was disagreement on 
the severity of left ventricular (LV) dysfunction, the echo-
cardiogram was reviewed jointly with the third operator and 
a consensus reached. Left ventricular ejection fraction 
(LVEF) was calculated using the Simpson’s formula from 
measurements of end-diastolic and end-systolic volumes on 
apical 2D views, following the guidelines of Schiller and 
colleagues [8] and LVSD was diagnosed if LVEF was 
45%.  
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 Patients underwent a symptom-limited, treadmill-based 
maximal CPET using the Bruce protocol modified by the 
addition of a Stage 0 (2.74 km·h
-1
 and 0% gradient). Meta-
bolic gas exchange was measured with an Oxycon Delta 
metabolic cart (VIASYS Healthcare Inc., Philadelphia, PA). 
Peak oxygen uptake (pVO2) was calculated as the average 
VO2 for the final 30s of exercise. The ventilatory anaerobic 
threshold (VAT) was calculated by the V-slope method [9]. 
The VE/ VCO2 ratio was calculated by linear regression 
analysis using data acquired from the whole test. The peak 
respiratory exchange ratio (pRER) was calculated as the 
mean VCO2/VO2 ratio for the final 30s of exercise. Blood 
pressure (BP) was measured using an automated blood pres-
sure monitor (SunTech Tango, USA). Resting BP and heart 
rate (HR) were measured following 10 min of rest in a su-
pine position. The DPR was calculated as the product of 
peak systolic blood pressure and peak heart rate subtracted 
from the product of resting systolic blood pressure and rest-
ing heart rate values.  
Statistical Analysis 
 SPSS (version 14.0) was used to analyse the data. Con-
tinuous variables are presented as mean ± SD, and categori-
cal data are presented as percentages. Continuous variables 
were assessed for normality by the Kolmogorov-Smirnov 
test. We used Pearson correlation coefficients to calculate 
association between variables. An independent samples t-test 
was used to calculate differences between alive and deceased 
patients at 12 months. An arbitrary level of 5% statistical 
significance was used throughout (two-tailed).  
 All survivors were followed for a minimum of 12 months 
and we therefore give the probability of 12-month survival. 
All baseline variables (Table 1) were entered as potential 
univariate predictors of mortality using Cox analysis. Model 
building was based on backwards elimination (P-value for 
entry was <0.05; P-value for removal >0.1). A multivariate 
Cox proportional hazards model using backwards elimination 
was used to identify independent predictors of all-cause mortal-
ity from the remaining univariate predictors. Our outcome 
measure was all-cause mortality. 
RESULTS 
 363 patients (mean ± SD; age 74±11 years; 81% males; 
LVEF 34±6%; peak VO2 19.0 ± 5.1 mL·kg
-1
·min
-1
;VE/VCO2 
slope 37 ± 9; DPR 10,510 ± 6,046 mmHg·beat
-1
) were in-
Table 1. Clinical Characteristics of Patients with CHF 
Variable (mean ± SD) Alive at 1 Year Dead at 1 Year P-Value 
N 311 52 - 
Males (%) 80 83 0.65 
Age (years) 73 (11) 74 (11) 0.69 
BMI (kg·m-2) 28 (5) 26 (5) 0.10 
LVEF (%) 34 (6) 34 (7) 0.84 
pVO2 (mL·kg
-1·min-1) 19.6 (5.0) 16.1 (4.4) 0.0001* 
VE/VCO2 slope (full) 38.0 (9.0) 38.8 (9.7) 0.86 
AT (mL·kg-1·min-1) 18.1 (6.8) 11.1 (3.5) 0.40 
pRER 1.00 (0.11) 1.03 (0.12) 0.11 
Exercise duration (s) 469 (208) 398 (202) 0.024* 
RHR (beats·min-1) 75 (16) 78 (16) 0.37 
PHR (beats·min-1) 127 (27) 126 (32) 0.67 
Heart rate reserve 52 (23) 48 (31) 0.29 
SBP (rest) (mmHg) 135(25) 130 (22) 0.15 
SBP (peak) (mmHg) 163 (34) 153 (33) 0.049* 
Systolic BP reserve 28 (28) 23 (28) 0.27 
DBP (rest) (mmHg) 84 (14) 80 (21) 0.15 
DBP (peak) (mmHg) 92 (22) 85 (21) 0.045* 
DPR (mmHg·beat-1) 10,704 (5,945) 9,348 (6,563) 0.14 
Loop diuretic (%) 72 77 0.07 
ACE-I (%) 76 83 0.11 
Beta-blocker (%) 63 74 0.04* 
BMI: body mass index; LVEF: left ventricular ejection fraction; pVO2: peak oxygen uptake; ACE-I: ACE-inhibitor; RHR: resting heart rate; PHR: peak heart rate; SBP: systolic 
blood pressure; DBP: diastolic blood pressure; pRER: peak respiratory exchange ratio; DPR: double pressure reserve; AT: anaerobic threshold; * Significant difference, P <0.05 
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cluded in the study. Of these, 78% were prescribed ACE-
inhibitors, 67% beta-blockers, and 73% loop diuretics. Table 
1 shows the clinical characteristics of patients included in the 
study.  
 Patients who had deceased at 12 months, had lower peak 
oxygen uptake, exercise duration, peak systolic BP, and peak 
diastolic BP than alive patients (P <0.05; Table 1). There 
was a weak negative correlation between resting HR and 
resting systolic BP (r = -0.15; P = 0.004), and a weak corre-
lation between heart rate reserve and systolic BP reserve (r = 
0.27; P = 0.0002). The DPR was moderately correlated with 
peak oxygen uptake (r =0.45; P=0.001; Fig. 1) but showed 
no association with VE/VCO2 slope (r =-0.08; P=0.157).  
 During continued follow up, 87 patients died represent-
ing a crude death rate of 24%. In surviving patients, the me-
dian follow up (inter-quartile range) was 42 (34-50) months. 
Higher DPR did appear to be related to a better survival, but 
this effect did not reach statistical significance. By contrast, 
Kaplan-Meier curves for peak oxygen uptake show a greater 
separation between quartile ranges (log rank 2 = 27; P = 
0.001) than for DPR (log rank 2 = 9; P = 0.65) (Figs. 2 & 
3).  
 All the variables in Table 1 were included as potential 
candidate univariate predictors of outcome in a Cox model. 
Six variables met the inclusion criterion (P<0.1); peak VO2, 
VE/VCO2 slope, LVEF, age, heart rate (rest), BMI (Table 2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Relation between peak oxygen uptake and double pressure reserve in CHF. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Kaplan-Meier curve showing prognostic value of peak oxygen uptake in CHF. 
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and were included in the Cox multivariate regression model. 
DPR was not a univariate predictor of mortality (P=0.7; 
HR=1.0; 95% CI = 0.99-1.0). The strongest predictors of all-
cause mortality was peak oxygen uptake (HR= 0.87; 
P<0.001; 95% CI=0.75-0.99) followed by the VE/VCO2 
slope (Table 3).  
DISCUSSION 
 The DPR is not an independent predictor of mortality 
during exercise testing with metabolic gas exchange in pa-
tients with CHF. Rafie et al. [6] reported that lower DPR 
was an independent predictor of cardiovascular mortality in 
men referred for assessment of potential coronary disease, 
both in those with established cardiovascular disease and 
those without. The mean DPR value (10,510 ± 6,046 
mmHg·beat
-1
) in our patients was similar to that reported by 
Rafie [6] in patients with CV disease (10,392 ± 4,846 
mmHg·beat
-1
).  
 The DPR has been shown to be directly related to exer-
cise capacity (METs) and heart rate recovery (HRR), and a 
DPR of  10,000 mmHg·beat-1 is a strong and independent 
predictor of CV mortality [6]. A low DPR is a stronger pre-
dictor of an increased risk of death than traditional risk fac-
tors such as smoking, diabetes, and exercise-related markers 
such as maximal HR, HRR, or exercise capacity. However, 
the authors were not able to measure metabolic gas exchange 
and thus were not able to compare the value of DPP against 
known predictors of mortality such as peak oxygen uptake 
and VE/VCO2 slope [5, 6, 10]. Further, they did not include 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Kaplan-Meier curve showing prognostic value of the double pressure reserve in CHF. 
Table 2. Univariate Cox Regression Analysis (P<0.1 for Inclusion) 
Variables P-Value HR 95% CI  2 
Peak VO2  <0.001 0.9 0.8-0.9 36.8 
VE/VCO2 slope 0.04 1.03 1.00-1.06 12.6 
Age 0.02 0.97 0.95-0.99 12.3 
LVEF 0.1 0.97 0.93-1.01 3.3 
Heart rate (rest) 0.1 1.01 0.99-1.02 1.1 
BMI 0.1 0.98 0.94-1.01 2.8 
HR = hazard ratio; CI = confidence interval; 2 = Chi-square; LVEF = left ventricular ejection fraction; BMI = body mass index. 
 
Table 3. Multivariate Cox Regression Analysis 
Variable P-Value HR 95% CI  2 
Age 0.09 1.02  0.98-1.05 3.0 
Peak VO2 <0.001 0.87 0.75-0.99 11.8 
VE/VCO2 slope 0.04 1.03 1.00-1.07 4.0 
2500 2000 1500 1000 500 0 
Days Alive 
1.0 
0.8 
0.6 
0.4 
0.2 
0.0 
 Survival (%) 
6080 – 9747 (n = 91) 
9748 – 14162 (n = 91) 
>14162 (n = 91)  
Double product reserve (quartile ranges; mmHg·beat-1) 
<6080 (n = 90) 
Log Rank chi2 = 9; P = 0.65 
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patients with CHF. We have shown that prognostic markers 
derived from metabolic gas exchange are more important 
than DPR in patients with CHF. The double (rate-pressure) 
product has been used as an estimate of the maximal per-
formance of the left ventricle during exercise testing [6], and 
is an indirect marker of myocardial oxygen consumption 
[11]. However, it does not have any prognostic value in our 
cohort of CHF patients.  
Limitations 
 We only evaluated the prognostic impact of DPR against 
all-cause mortality. We were unable to assess cause-specific 
mortality in our subset of CHF patients. 
CONCLUSION 
 In CHF, the DPR is not an independent predictor of mor-
tality. Traditional prognostic markers derived from meta-
bolic gas exchange including peak VO2 and the VE/VCO2 
slope are more important. We recommend that exercise test-
ing with metabolic gas exchange should be incorporated into 
clinical practice in order to improve prognostic predictive 
power in patients with CHF.  
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